Outgoing CEO Kevin Sayer expects expanding coverage of Dexcom’s glucose sensors for people with Type 2 diabetes and ...

Medical device company DexCom (NASDAQ:DXCM) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 15.2% year on ...

DexCom, Inc . DXCM reported second-quarter 2025 adjusted earnings per share (EPS) of 48 cents, which beat the Zacks Consensus ...

After taking on the title of president earlier this year, Dexcom’s Jake Leach will be stepping into the role of CEO at the ...

Innovations are expanding the number of people who can benefit from continuous glucose monitoring and a recent move by ...

DexCom, Inc., the global leader in glucose biosensing, announced today it has released a new AI-powered photo meal logging ...

SAN DIEGO - Dexcom reported revenue growth of 15% year-over-year to $1.157 billion for the second quarter of 2025.

DexCom reports 15% Q2 2025 revenue growth, boosted by expanded type 2 diabetes access & product innovation. Discover their raised outlook & future plans.

Dexcom ( ($DXCM) ) has released its Q2 earnings. Here is a breakdown of the information Dexcom presented to its investors. Dexcom, Inc., a leader ...

RIZZ - World's Smartest Ring Now available for pre-order, RIZZ brings real-time glucose, sleep, and stress tracking to your finger without ...

Stelo, the first FDA-cleared over-the-counter glucose biosensor, joins the G7 continuous glucose monitor (CGM) in offering ...